[US-Korea Conference] Innovation and Entrepreneurship Symposium (IES) & Startup Pitch Competition (Dec 15 – 18, 2021 @ Hyatt Regency Orange County, Garden Grove, CA)

KSEA(Korean-American Scientists and Engineers Association) is hosting its 3rd Innovation and Entrepreneurship Symposium (IES) during the US-Korea Conference on  December 15 – 18, 2021 at the Hyatt Regency Orange County, Garden  Grove, CA.  The symposium seeks to provide a cooperative environment for current and future aspiring entrepreneurs in the US and Korea to network with high-profile entrepreneurs and investors, listen to the stories of those who have successfully exited their companies, and learn about the best practices of startups, from protecting your intellectual property and assets to securing funding from venture capitalists and government agencies. The symposium program and additional information can be viewed on the UKC website and from the attached program overview.

For budding entrepreneurs, come pitch to potential investors at the Startup Pitch Competition about how your solution seeks to improve the synergy between the US and  Korea. We invite all entrepreneurial-minded American and Korean professionals to attend the IES during UKC 2021 and learn about growing cross-border business opportunities in the US and Korea today. About ten competition finalists will go head-to-head to compete for various awards, including cash awards. Additional details, including eligibility requirements and timeline, can be found here and from the attached program overview and the flyer.

Interested in competing? Apply at https://bit.ly/3jQzJ64 by Friday, October 1, 2021, 11:59 EDT. 

Questions? Send an email at spc.ksea@gmail.com.

We invite all entrepreneurial-minded professionals and students to attend the IES during UKC 2021 and learn about the continually growing cross-border partnership opportunities in the US and Korea. 

Thank you.

Byungkyu Brian Park, UKC 2021 Chair and KSEA President

Woo Il Lee, UKC 2021 Co-Chair and KOFST President

IES Organizing Committee Co-Chairs

Kyeong Ho Yang (Chair, KITEE) IL Minn (Co-Chair, Competition, Johns Hopkins University) Jeho Park (Co-Chair, Program, Claremont McKenna College) Kwangrog Kim (Co-Chair, Entrepreneurship, Primer Sazze Partners)

「포스트 코로나 시대 바이오헬스 분야 한국기업 미국진출 전략」 온/오프라인 세미나 (Washington DC, 주미한국대사관)

보건복지부 메디컬코리아 거점 공관 지원사업으로 개최하는 본 행사는 주미대사관이 주최하고, KAPAL과 진흥원 미국지사에서 공동으로 주관하는 바이오헬스 한국기업 미국진출 전략 세미나입니다.

주미대사관(김상희 공사참사관 총괄) 주최, KAPAL과 진흥원 미국지사 공동 주관

바이오헬스 한국기업 미국진출 전략 온/오프라인 세미나

시간
미국 (동부): July 15, 2021 (Thr) 7:00 – 8:00 PM EDT (1부, Dinner & Networking)
8:00 – 9:50 PM EDT (2부, Seminar – Online 생중계)
한국: 7월 16일 (금요일) 9:00 – 10:50 AM KST (Online webinar)

장소
워싱턴 DC 주미한국대사관 1층 대회의실
2450 Massachusetts Ave NW, Washington, DC 20008
* On site Seminar는 CDC(미국 질병통제예방센터) 기준으로 코로나 백신 완전 접종자에 한해 현장 행사 참석 예정입니다.

[한국보건산업진흥원] 해외 의료기기 전문가 (GMKOL) 전문위원 모집 공고

국내 의료기기 기업의 글로벌 시장 진출 경쟁력 확보 및 글로벌 네트워크 강화를 위하여 Global Medical device Key Opinion Leaders (이하 “GMKOL”) 전문위원을 위촉하고자 합니다. 이에 의료기기 해외진출 정보 및 컨설팅 제공이 가능한 권역별/ 분야별 ‘GMKOL 전문위원’을 다음과 같이 공개 모집 하오니 의료기기 해외진출 전문가의 많은 참여를 바랍니다.

7th KAPAL On-Air Webinar (June 24, 2021, 9:00 – 10:30 PM EST)

2021 KAPAL–KHIDI Bio & Health Webinar Series는 한미생명과학인 협회 (KAPAL)와 KHIDI 미국지사 웨비나 시리즈입니다.

About this event

KAPAL 7th On-Air Webinar

(2021 KAPAL-KHIDI Webinar Series #2)

Title: Use of Real-World Data and Real-World Evidence in Drug Development

The 21st Century Cures Act established a program to evaluate the potential use of real-world evidence (RWE) to help to support the approval of a new indication for a drug approved and to help to support or satisfy post-approval study requirements. Accordingly, the FDA has been exploring the potential use of Real World Data (RWD) in regulatory decision making. This presentation will start with general overview of Real-World Data and Real-World Evidence in drug development and introduction to observational studies and causal inference. Th challenges with RWD/RWE will be discussed from multiple aspects including data quality, study design and statistical methods to adjust potential confounding. At the end of presentation, case studies will be presented.

About the presenter:

Joo-Yeon Lee, Ph.D.

Senior Statistical Reviewer, FDA

Joo-Yeon Lee, Ph.D. is a senior statistician of Division of Biometrics VII in the Office of Biostatistics in the Center for Drug Evaluation and Research at the FDA. She has received a B.S in statistics from Ewha Womans University, M.A and Ph.D. in Biostatistics from Brown University. Since joining FDA in 2007, Dr. Lee has been working as a pharmacometrics reviewer for new drug applications and a statistical reviewer for post-market drug safety studies. Dr. Lee has been playing a major role in many working groups on causal inference methods within the FDA. In addition, Dr. Lee has involved in FDA-led drug safety studies utilizing sentinel data and other data source such as UK Clinical Practice Research Datalink (CPRD) as a collaborator. Dr. Lee has taught the inverse probability weighting method with a case study at causal inference workshop at FDA in November 2017 and short courses at DIA/FDA Biostatistics Industry and Regulator Forum in April 2018 and ASA Biopharmaceutical section regulatory-industry statistics workshop in September 2020. Currently, Dr. Lee has main interest in the causal inference in observational studies, especially methods for sensitivity analysis for unmeasured confounder(s) and is an active member of quantitative bias analysis working group and serves as FDA statistical collaborator of FDA-funded project that aims to evaluate methods for assessment of potential for bias due to uncontrolled confounding.

7th KAPAL On-Air webinar materials